Trials / Recruiting
RecruitingNCT07314359
Rapid Effects of a Biofield Patch on Antioxidant Status and Cellular Energy
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Natural Immune Systems Inc · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The goal for this clinical proof-of-concept study is to compare an active biofield skin patch to a placebo patch on antioxidant function and mitochondrial function. A double-blind, placebo-controlled cross-over study design will be used.
Detailed description
The goal for this clinical proof-of-concept study is to document acute effects of a photobiomodulating non-transdermal patch compared to a placebo patch, in an acute randomized double-blind placebo-controlled cross-over design. An add-on open-label module involves wearing the active patch daily for a week before the final clinic visit. Data on endogenous antioxidant protection will be collected. The testing will show whether wearing the patch leads to a change in antioxidant activity of superoxide dismutase and glutathione. Data on cellular energy production and mitochondrial resilience in white blood cells under oxidative and inflammatory stress ex vivo will be collected. This testing will show whether using the active patch leads to changes in mitochondrial biogenesis and mitochondrial energy production under normal versus ex vivo-stressed conditions. Data on serum cytokine levels in both serum and serum-derived extracellular vesicles will be collected. The testing will show whether wearing the patch contributes to rapid change in pro- and anti-inflammatory markers and restorative growth factors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Active dermal patch | Non-transdermal patch |
| OTHER | Placebo dermal patch | Non-transdermal patch |
Timeline
- Start date
- 2025-12-04
- Primary completion
- 2026-07-01
- Completion
- 2026-08-01
- First posted
- 2026-01-02
- Last updated
- 2026-01-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07314359. Inclusion in this directory is not an endorsement.